IL6 and familial pancreatic carcinoma: Huang et al. demonstrated that abnormal activation of the IL-6 (interleukin-6)/STAT3 (signal transducer and activator of transcription 3) signaling pathway promotes transcriptional repression of SOCS3 by increasing DNMT1 activity, which can lead to the growth and metastasis of pancreatic cancer.